Categories: BioTechBuildingDesignDevelopmentDrugHealthTechIndustryPlatform
Breakthru Medicine focuses on aggressive solid tumors with the highest unmet need—cancers where patients have exhausted existing options. By attacking the specific molecular drivers of each tumor, we design precision therapies for patients whose cancers have become resistant to current treatments.
Investors 1
Mentions in press and media 2
| Date | Title | Description |
| 13.02.2026 | Breakthru Medicine Snares $60 Million Series A |
PHOENIX, AZ, Breakthru Medicine has emerged from stealth with the close of a $60M Series A financing round following a prior undisclosed seed round.
>> Click here for more funding data on Breakthru Medicine
>> To export Breakth... |
| - | Breakthru Medicine | “Home | Breakthru Medicine” |
Reviews 0
